Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma.
Kaposi's sarcoma (KS) is an angioproliferative disease particularly frequent and aggressive in patients with AIDS but occurring also in post-transplant patients or in immunocompetent individuals of certain geographic areas. At least in its early stages, KS behaves as a reactive hyperplastic process mediated by inflammatory cytokines and angiogenic factors triggered or exacerbated by human herpesvirus-8 (HHV-8) infection. The HIV Tat protein appears to be responsible for the highly aggressive nature of AIDS-KS. Over time, however, KS may evolve into a true sarcoma in association with the expression of oncogenes and/or HHV-8 latency genes endowed with growth and anti-apoptotic properties. HHV-8 infection is also associated with primary effusion lymphoma (PEL), a rare tumor that similarly develops more frequently in the setting of HIV infection. HHV-8 latency genes are likely to contribute to the neoplastic phenotype of PEL cells, whose growth in vivo may require cytokines and factors from the host, or encoded by the virus.
Ensoli
B
B
Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy. ensoli@iss.it
Stürzl
M
M
Monini
P
P
D043925:Angiogenesis Inducing Agents / Q000502:physiology; D002455:Cell Division; D018925:Chemokines / Q000502:physiology; D016207:Cytokines / Q000502:physiology*; D015696:Gene Products, tat / Q000502:physiology; D019254:Genes, bcl-2; D019288:Herpesvirus 8, Human / Q000235:genetics; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000473:pathology*; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000473:pathology*
D043925:Angiogenesis Inducing Agents; D018925:Chemokines; D016207:Cytokines; D015696:Gene Products, tat